CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Sapropterin dihydrochloride

Last Updated: July 8, 2010
Result type: Reports
Project Number: SR0205-000
Product Line: Reimbursement Review

Generic Name: Sapropterin dihydrochloride

Brand Name: Kuvan

Manufacturer: BioMarin Pharmaceutical Canada Inc.

Therapeutic Area: Phenylketonuria (PKU)

Indications: Phenylketonuria (PKU).

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: January 26, 2011

Recommendation Type: Do not list